asfotase alfa

FDA Drug Profile

asfotase alfa is listed in the FDA National Drug Code directory with 4 NDC codes. Available dosage form: solution.

Drug details

Generic Name
asfotase alfa
Sponsor
Patheon Italia S.P.A.
NDC Codes
4
Dosage Forms
SOLUTION
Active Ingredients
ASFOTASE ALFA

Indications and Usage

1 INDICATIONS AND USAGE STRENSIQ ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). STRENSIQ is a tissue nonspecific alkaline phosphatase indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.